Ribavirin trial in cases of infective hepatitis
Kumta, N.B.; Antani, D.N.
Indian Pediatrics 20(2): 99-103
1983
ISSN/ISBN: 0019-6061 PMID: 6345384 Document Number: 210044
Document emailed within 1 workday
Related Documents
Roberts, R.B.; Dickinson, G.M.; Heseltine, P.N.; Leedom, J.M.; Mansell, P.W.; Rodriguez, S.; Johnson, K.M.; Lubina, J.A.; Makuch, R.W. 1990: A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. the Ribavirin-LAS Collaborative Group Journal of Acquired Immune Deficiency Syndromes 3(9): 884-892Bizid, S.; Ben Abdallah, H.; Kilani, I.; Mohamed, G.; Bouali, R.; Abdelli, N. 2013: Predictive factors of response to peginterferon and ribavirin in Tunisians patients with chronic hepatitis C: report of 141 cases La Tunisie Medicale 91(5): 327-331
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Abramowicz, M. 2007: Peginterferon and ribavirin for hepatitis C New England Journal of Medicine 356(12): 1270-1271; Author Reply 1271
Arase, Y. 2011: Combination therapy of PEG-interferon and ribavirin for chronic hepatitis C in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 191-195
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Roznovský, L.; Orságová, I.; Petrousová, L.; Mrázek, J.; Kloudová, A.; Kabieszová, L.; Kůrková, J.; Pospísek, M. 2010: Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences Klinicka Mikrobiologie a Infekcni Lekarstvi 16(2): 73-75
Varghese, R.; Al-Khaldi, J.; Asker, H.; Fadili, A.A.; Al Ali, J.; Hassan, F.A. 2009: Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin Hepato-Gastroenterology 56(89): 218-222
Nunnari, G.; Montineri, A.; Portelli, V.; Savalli, F.; Fatuzzo, F.; Cacopardo, B. 2012: The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C European Review for Medical and Pharmacological Sciences 16(8): 1013-1016
Goulon, M.; Rapin, M.; Barois, A.; Got, C.; Grobuis, S.; Gajdos, P.; Azizi, P. 1971: Trial treatment of severe viral hepatitis with hyperbaric oxygenation (apropos of 16 cases) Annales de Medecine Interne 122(1): 93-98
Shakeel Ahmad, J.; Ashfaa, A.; Habib Ahmad, J. 2014: Effect of standard interferon and ribavirin on haemoglobin level in hepatitis-C patients Journal of Ayub Medical College Abbottabad: Jamc 26(4): 510-512
Sajjad, S.F.; Ahmed, W.u.; Arif, A.; Alam, S.E.; Waquar, J. 2012: Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients JPMA. Journal of the Pakistan Medical Association 62(11): 1229-1232
Karim, A.; Ahmed, S.; Khan, A.; Steinberg, H.; Mattana, J. 2001: Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection American Journal of the Medical Sciences 322(4): 233-235
Anand, A.C.; Seth, A.K.; Nagpal, A.; Varma, P.P.; Gadela, S.R.; Baliga, K.V.; Dutta, V.; Chopra, G.S. 2004: Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(6): 226-227
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660
Watson, J. 2002: Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin Current Opinion in Investigational Drugs 3(5): 680-683
Khokhar, N. 2002: Effectiveness of 48 weeks Interferon alfa-2b in combination with ribavirin as initial treatment of chronic hepatitis Journal of Ayub Medical College Abbottabad: Jamc 14(3): 5-8
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133